Belgium · Delayed Price · Currency is EUR Onward Medical Statistics
Total Valuation
Onward Medical has a market cap or net worth of EUR 173.63 million. The enterprise value is 119.18 million.
| Market Cap | 173.63M |
| Enterprise Value | 119.18M |
Important Dates
The last earnings date was Tuesday, March 31, 2026.
| Earnings Date | Mar 31, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Onward Medical has 56.01 million shares outstanding. The number of shares has increased by 4.58% in one year.
| Current Share Class | 56.01M |
| Shares Outstanding | 56.01M |
| Shares Change (YoY) | +4.58% |
| Shares Change (QoQ) | +9.11% |
| Owned by Insiders (%) | 1.50% |
| Owned by Institutions (%) | 22.72% |
| Float | 42.89M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 32.07 |
| PB Ratio | 3.14 |
| P/TBV Ratio | 3.73 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -2.85 |
| EV / Sales | 22.01 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -3.02 |
Financial Position
The company has a current ratio of 6.67, with a Debt / Equity ratio of 0.25.
| Current Ratio | 6.67 |
| Quick Ratio | 6.40 |
| Debt / Equity | 0.25 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.35 |
| Interest Coverage | -18.71 |
Financial Efficiency
Return on equity (ROE) is -80.85% and return on invested capital (ROIC) is -38.68%.
| Return on Equity (ROE) | -80.85% |
| Return on Assets (ROA) | -31.80% |
| Return on Invested Capital (ROIC) | -38.68% |
| Return on Capital Employed (ROCE) | -55.66% |
| Weighted Average Cost of Capital (WACC) | 9.88% |
| Revenue Per Employee | 52,563 |
| Profits Per Employee | -405,699 |
| Employee Count | 103 |
| Asset Turnover | 0.07 |
| Inventory Turnover | 2.30 |
Taxes
In the past 12 months, Onward Medical has paid 311,000 in taxes.
| Income Tax | 311,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -12.43% in the last 52 weeks. The beta is 0.98, so Onward Medical's price volatility has been similar to the market average.
| Beta (5Y) | 0.98 |
| 52-Week Price Change | -12.43% |
| 50-Day Moving Average | 3.84 |
| 200-Day Moving Average | 4.38 |
| Relative Strength Index (RSI) | 30.14 |
| Average Volume (20 Days) | 153,754 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Onward Medical had revenue of EUR 5.41 million and -41.79 million in losses. Loss per share was -0.90.
| Revenue | 5.41M |
| Gross Profit | 4.38M |
| Operating Income | -40.89M |
| Pretax Income | -41.48M |
| Net Income | -41.79M |
| EBITDA | -40.38M |
| EBIT | -40.89M |
| Loss Per Share | -0.90 |
Balance Sheet
The company has 68.11 million in cash and 13.67 million in debt, with a net cash position of 54.45 million or 0.97 per share.
| Cash & Cash Equivalents | 68.11M |
| Total Debt | 13.67M |
| Net Cash | 54.45M |
| Net Cash Per Share | 0.97 |
| Equity (Book Value) | 55.32M |
| Book Value Per Share | 0.99 |
| Working Capital | 62.98M |
Cash Flow
In the last 12 months, operating cash flow was -39.07 million and capital expenditures -432,000, giving a free cash flow of -39.50 million.
| Operating Cash Flow | -39.07M |
| Capital Expenditures | -432,000 |
| Depreciation & Amortization | 509,000 |
| Net Borrowing | -600,000 |
| Free Cash Flow | -39.50M |
| FCF Per Share | -0.71 |
Margins
| Gross Margin | 80.81% |
| Operating Margin | -755.17% |
| Pretax Margin | -766.09% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Onward Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -4.58% |
| Shareholder Yield | -4.58% |
| Earnings Yield | -24.07% |
| FCF Yield | -22.75% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Onward Medical has an Altman Z-Score of 0.02 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.02 |
| Piotroski F-Score | 5 |